Gossamer Bio Ownership 2024 | Who Owns Gossamer Bio Now?
Institutional Ownership
80.78%
Insider Ownership
2.95%
Retail Ownership
16.27%
Institutional Holders
93.00
Gossamer Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 8.02% | 1.23% | 18,093,034 | 2,255,025 | 14.24% | 16,300,014 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 5.90% | 0.31% | 13,308,968 | - | - | 11,990,049 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.21% | 0.00% | 11,760,251 | -3,533 | -0.03% | 10,594,810 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 4.07% | 1.30% | 9,187,883 | - | - | 8,277,364 | Jun 30, 2024 |
| ARCH VENTURE MANAGEMENT, LLC | 3.57% | 2.73% | 8,055,916 | - | - | 7,257,575 | Jun 30, 2024 |
| FMR LLC | 3.51% | 0.00% | 7,930,508 | -258,639 | -3.16% | 7,144,595 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 2.78% | 0.66% | 6,277,093 | -114,682 | -1.79% | 5,655,033 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 2.72% | 1.16% | 6,130,268 | - | - | 5,522,758 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.55% | 0.39% | 5,750,000 | 2,500,000 | 76.92% | 5,180,175 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.48% | 0.00% | 5,597,378 | -898,042 | -13.83% | 5,042,678 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.44% | 1.17% | 5,500,000 | -630,268 | -10.28% | 4,954,950 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.43% | 0.00% | 5,494,794 | 2,603,789 | 90.07% | 4,946,000 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 2.43% | 0.03% | 5,487,516 | 5,487,516 | 100.00% | 4,943,703 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 2.43% | 0.34% | 5,484,148 | -510,324 | -8.51% | 4,940,669 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 2.20% | 0.11% | 4,974,041 | - | - | 4,481,114 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.73% | 0.80% | 3,910,000 | 1,469,891 | 60.24% | 3,522,519 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.69% | 0.00% | 3,807,661 | - | - | 3,426,895 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.59% | 0.01% | 3,592,765 | 856,380 | 31.30% | 3,235,000 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1.56% | 0.13% | 3,524,908 | -1,169,157 | -24.91% | 3,175,590 | Jun 30, 2024 |
| CI PRIVATE WEALTH, LLC | 1.50% | 0.01% | 3,391,483 | 119,213 | 3.64% | 3,055,388 | Jun 30, 2024 |
Gossamer Bio's largest institutional shareholder is NEA MANAGEMENT COMPANY, LLC, holding 8.02% of the company's total share outstanding, currently valued at $16.30M. The top 10 institutional shareholders own together 40.80% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARCH VENTURE MANAGEMENT, LLC | 3.57% | 2.73% | 8,055,916 | - | - | 7,257,575 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 4.07% | 1.30% | 9,187,883 | - | - | 8,277,364 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 8.02% | 1.23% | 18,093,034 | 2,255,025 | 14.24% | 16,300,014 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.44% | 1.17% | 5,500,000 | -630,268 | -10.28% | 4,954,950 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 2.72% | 1.16% | 6,130,268 | - | - | 5,522,758 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.50% | 0.88% | 1,127,699 | 1,127,699 | 100.00% | 1,015,944 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.73% | 0.80% | 3,910,000 | 1,469,891 | 60.24% | 3,522,519 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 2.78% | 0.66% | 6,277,093 | -114,682 | -1.79% | 5,655,033 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 1.21% | 0.39% | 2,726,104 | 2,170,104 | 390.31% | 2,455,947 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.55% | 0.39% | 5,750,000 | 2,500,000 | 76.92% | 5,180,175 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 2.43% | 0.34% | 5,484,148 | -510,324 | -8.51% | 4,940,669 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 5.90% | 0.31% | 13,308,968 | - | - | 11,990,049 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.62% | 0.30% | 1,409,262 | - | - | 1,269,604 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1.56% | 0.13% | 3,524,908 | -1,169,157 | -24.91% | 3,175,590 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.06% | 0.12% | 138,176 | - | - | 124,483 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 2.20% | 0.11% | 4,974,041 | - | - | 4,481,114 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.38% | 0.10% | 859,854 | -2,600,000 | -75.15% | 774,642 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.24% | 0.09% | 532,628 | -200,000 | -27.30% | 479,845 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.45% | 0.09% | 3,266,960 | - | - | 2,943,204 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.30% | 0.04% | 672,856 | - | - | 623,065 | Jun 30, 2024 |
The largest Gossamer Bio shareholder by % of total assets is ARCH VENTURE MANAGEMENT, LLC. The company owns 8.06M shares of Gossamer Bio (GOSS), representing 2.73% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALYESKA INVESTMENT GROUP, L.P. | 2.43% | 0.03% | 5,487,516 | 5,487,516 | 100.00% | 4,943,703 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.43% | 0.00% | 5,494,794 | 2,603,789 | 90.07% | 4,946,000 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.55% | 0.39% | 5,750,000 | 2,500,000 | 76.92% | 5,180,175 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 8.02% | 1.23% | 18,093,034 | 2,255,025 | 14.24% | 16,300,014 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 1.21% | 0.39% | 2,726,104 | 2,170,104 | 390.31% | 2,455,947 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.48% | 0.00% | 3,335,511 | 2,103,766 | 170.80% | 3,001,962 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.73% | 0.80% | 3,910,000 | 1,469,891 | 60.24% | 3,522,519 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.91% | 0.00% | 2,046,600 | 1,375,000 | 204.74% | 1,843,782 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.50% | 0.88% | 1,127,699 | 1,127,699 | 100.00% | 1,015,944 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.51% | 0.01% | 1,156,236 | 975,678 | 540.37% | 1,041,650 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.59% | 0.01% | 3,592,765 | 856,380 | 31.30% | 3,235,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.34% | 0.00% | 769,628 | 769,628 | 100.00% | 693,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.35% | 0.01% | 781,778 | 603,836 | 339.34% | 704,304 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.24% | 0.01% | 552,000 | 535,000 | 3147.06% | 497,297 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.28% | 0.00% | 641,498 | 219,238 | 51.92% | 577,926 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.09% | 0.03% | 2,463,647 | 162,796 | 7.08% | 2,219,499 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.14% | 0.00% | 310,213 | 124,913 | 67.41% | 279,471 | Jun 30, 2024 |
| CI PRIVATE WEALTH, LLC | 1.50% | 0.01% | 3,391,483 | 119,213 | 3.64% | 3,055,388 | Jun 30, 2024 |
| SMITH, MOORE & CO. | 0.10% | 0.02% | 226,000 | 100,000 | 79.37% | 203,603 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.04% | 0.00% | 83,543 | 83,543 | 100.00% | 75,000 | Jun 30, 2024 |
As of Jun 30 2024, Gossamer Bio's largest institutional buyer is ALYESKA INVESTMENT GROUP, L.P.. The company purchased 5.49M stocks of GOSS, valued at $4.94M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | - | - | - | -9,195,404 | -100.00% | - | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -6,130,272 | -100.00% | - | Jun 30, 2024 |
| MADISON AVENUE PARTNERS, LP | - | - | - | -4,140,773 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.09% | - | 194,664 | -4,140,436 | -95.51% | 175,373 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.38% | 0.10% | 859,854 | -2,600,000 | -75.15% | 774,642 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -1,366,769 | -100.00% | - | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1.56% | 0.13% | 3,524,908 | -1,169,157 | -24.91% | 3,175,590 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.48% | 0.00% | 5,597,378 | -898,042 | -13.83% | 5,042,678 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.10% | 0.03% | 222,134 | -805,000 | -78.37% | 200,121 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.44% | 1.17% | 5,500,000 | -630,268 | -10.28% | 4,954,950 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -592,889 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.94% | 0.00% | 2,117,714 | -576,251 | -21.39% | 1,907,849 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -562,061 | -100.00% | - | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 2.43% | 0.34% | 5,484,148 | -510,324 | -8.51% | 4,940,669 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.14% | 0.00% | 309,979 | -498,792 | -61.67% | 279,260 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.08% | 0.00% | 181,638 | -478,047 | -72.47% | 163,638 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -300,034 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 1.25% | 0.00% | 2,811,507 | -277,819 | -8.99% | 2,532,887 | Jun 30, 2024 |
| FMR LLC | 3.51% | 0.00% | 7,930,508 | -258,639 | -3.16% | 7,144,595 | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | - | - | - | -210,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Gossamer Bio's biggest institutional seller is ECOR1 CAPITAL, LLC. The company sold -9.20M shares of GOSS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EXOME ASSET MANAGEMENT LLC | 0.50% | 0.88% | 1,127,699 | 1,127,699 | 100.00% | 1,015,944 | Jun 30, 2024 |
| BARCLAYS PLC | 0.34% | 0.00% | 769,628 | 769,628 | 100.00% | 693,000 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.04% | 0.00% | 83,543 | 83,543 | 100.00% | 75,000 | Jun 30, 2024 |
| CHOREO, LLC | 0.02% | 0.00% | 48,111 | 48,111 | 100.00% | 45,590 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.02% | 0.00% | 40,000 | 40,000 | 100.00% | 36,036 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.01% | 0.00% | 20,000 | 20,000 | 100.00% | 18,018 | Jun 30, 2024 |
| TRELLIS WEALTH ADVISORS LLC | 0.01% | 0.01% | 15,000 | 15,000 | 100.00% | 13,514 | Jun 30, 2024 |
| MOORS & CABOT, INC. | 0.00% | 0.00% | 10,000 | 10,000 | 100.00% | 9,009 | Jun 30, 2024 |
| TRAYNOR CAPITAL MANAGEMENT, INC. | 0.00% | 0.00% | 10,000 | 10,000 | 100.00% | 9,009 | Jun 30, 2024 |
| CAPE INVESTMENT ADVISORY, INC. | 0.00% | 0.00% | 7,000 | 7,000 | 100.00% | 6,306 | Jun 30, 2024 |
| MFA WEALTH ADVISORS, LLC | 0.00% | 0.00% | 1,872 | 1,872 | 100.00% | 1,686 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 300 | 300 | 100.00% | 270 | Jun 30, 2024 |
Gossamer Bio's largest new institutional shareholder by number of shares is EXOME ASSET MANAGEMENT LLC, purchased 1.13M shares, valued at $1.02M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | - | - | - | -9,195,404 | -100.00% | - | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -6,130,272 | -100.00% | - | Jun 30, 2024 |
| MADISON AVENUE PARTNERS, LP | - | - | - | -4,140,773 | -100.00% | - | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -1,366,769 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -592,889 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -562,061 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -300,034 | -100.00% | - | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | - | - | - | -210,000 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -180,987 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -144,949 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -140,083 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -98,036 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -90,806 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -64,600 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -53,600 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -52,575 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -49,500 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -42,536 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -29,935 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -28,520 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -21,377 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -16,907 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -14,433 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -9,271 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Gossamer Bio's largest sold out institutional shareholder by shares sold is ECOR1 CAPITAL, LLC, sold -9.20M shares, valued at -, as of undefined.
Gossamer Bio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Clough Global Dividend & Income Fund | 10.19% | 1,070,000 | - | - | Jan 31, 2024 |
| Clough Global Equity Fund | 1.42% | 87,821 | - | - | Jan 31, 2024 |
| FORUM FUNDS | 0.87% | 2,000,000 | - | - | Jan 31, 2024 |
| Clough Funds Trust | 0.74% | 30,600 | - | - | Jan 31, 2023 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.47% | 978,914 | - | - | Feb 29, 2024 |
| Clough Global Opportunities Fund | 0.46% | 180,188 | - | - | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.31% | 1,039,680 | - | - | Mar 31, 2024 |
| UNIFIED SERIES TRUST | 0.24% | 3,750,000 | -1,250,000 | -25.00% | Mar 31, 2024 |
| Virtus Investment Trust | 0.19% | 6,625,000 | - | - | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.16% | 10,193,176 | -1,968,900 | -16.19% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.13% | 69,585 | - | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.13% | 44,956 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.11% | 894,500 | - | - | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.10% | 476,414 | - | - | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.08% | 42,380 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.08% | 1,570,000 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.08% | 178,900 | - | - | Mar 28, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.06% | 1,500,000 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.04% | 555,356 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.04% | 361,833 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.03% | 49,800 | - | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.03% | 143,664 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.03% | 28,000 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY GROWTH FUNDS, INC. | 0.03% | 4,397 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.03% | 67,978 | -797,210 | -92.14% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 10,720,535 | -2,843,811 | -20.97% | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 31,949 | - | - | Feb 29, 2024 |
| VANGUARD HORIZON FUNDS | 0.02% | 482,270 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.02% | 485,601 | - | - | Jan 31, 2024 |
| Bernstein Fund Inc | 0.02% | 148,270 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 99,288 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,395 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.01% | 2,170,774 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 17,496 | - | - | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.01% | 745,679 | - | - | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 312,832 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,921,201 | 43,335 | 2.31% | Feb 29, 2024 |
| LORD ABBETT INVESTMENT TRUST | 0.01% | 7,630,000 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.01% | 170 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,575 | - | - | Mar 31, 2024 |
| LAZARD FUNDS INC | 0.01% | 283,000 | - | - | Mar 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.01% | 522,621 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.01% | 74,040 | - | - | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 35,737 | - | - | Aug 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.01% | 1,178,000 | - | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 152,340 | -10,690 | -6.56% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 19,933 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 143,151 | -10,364 | -6.75% | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.00% | 317,246 | - | - | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 18,971 | - | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 18,486 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 156,778 | 118,234 | 306.75% | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 2,360 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 671,422 | 650,631 | 3129.39% | Jan 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.00% | 532 | - | - | Mar 28, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 15,489 | - | - | Mar 31, 2020 |
| VANGUARD WORLD FUND | 0.00% | 654,461 | 413,155 | 171.22% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 29,935 | -4,608 | -13.34% | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 125,198 | - | - | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 67,610 | - | - | Dec 31, 2023 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 11,100 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 5,276 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 1,092,890 | 37,184 | 3.52% | Feb 29, 2024 |
| North Square Investments Trust | 0.00% | 16,370 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 4,379 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 27,403 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 11,837 | - | - | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 30,602 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 467 | - | - | Apr 30, 2021 |
| NEW COVENANT FUNDS | 0.00% | 3,279 | - | - | Dec 31, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 24,100 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 1,660 | - | - | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 26,765,428 | - | - | Mar 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 376,000 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 157,000 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,096 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 30,495 | - | - | Jan 31, 2024 |
| AMERICAN FUNDS INSURANCE SERIES | 0.00% | 2,298,900 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 35,955 | - | - | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 80,016 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 15,700 | - | - | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 2,338 | - | - | Feb 29, 2024 |
| Trust for Advised Portfolios | 0.00% | 4,434 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 4,355 | - | - | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.00% | 5,578 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 18,300 | 1,000 | 5.78% | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 588 | - | - | Mar 28, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 555,936 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 580 | - | - | Dec 31, 2023 |
| MML Series Investment Fund II | 0.00% | 24,815 | - | - | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 8,359 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 388,825 | - | - | Mar 31, 2024 |
| BERNSTEIN SANFORD C FUND INC | 0.00% | 36,678 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 360 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,562 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 220,087 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 116,738 | - | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 43,025 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 10,786 | -1,414 | -11.59% | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 7,548 | - | - | Mar 31, 2024 |
Gossamer Bio's largest mutual fund holder by % of total assets is "Clough Global Dividend & Income Fund", owning 1.07M shares, compromising 10.19% of its total assets.
Gossamer Bio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 93 | -17.70% |
| 31 Mar, 24 | 113 | 11.88% |
| 31 Dec, 23 | 101 | 4.12% |
| 30 Sep, 23 | 97 | -4.90% |
| 30 Jun, 23 | 102 | -8.93% |
| 31 Mar, 23 | 112 | -10.40% |
| 31 Dec, 22 | 125 | -29.78% |
| 30 Sep, 22 | 178 | 26.24% |
| 30 Jun, 22 | 141 | -4.08% |
| 31 Mar, 22 | 147 | 6.52% |
| 31 Dec, 21 | 138 | 6.15% |
| 30 Sep, 21 | 130 | 10.17% |
| 30 Jun, 21 | 118 | -7.81% |
| 31 Mar, 21 | 128 | 0.79% |
| 31 Dec, 20 | 127 | -1.55% |
| 30 Sep, 20 | 129 | 13.16% |
| 30 Jun, 20 | 114 | 6.54% |
| 31 Mar, 20 | 107 | 10.31% |
| 31 Dec, 19 | 97 | 10.23% |
| 30 Sep, 19 | 88 | 18.92% |
| 30 Jun, 19 | 74 | 4.23% |
| 31 Mar, 19 | 71 | - |
As of 30 Jun 24, 93 institutions are holding Gossamer Bio's shares, representing a decrease of -17.70% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 182,340,737 | -7.82% |
| 31 Mar, 24 | 197,807,122 | -5.44% |
| 31 Dec, 23 | 209,180,750 | 2.23% |
| 30 Sep, 23 | 204,619,551 | 229.98% |
| 30 Jun, 23 | 62,010,363 | -20.17% |
| 31 Mar, 23 | 77,679,955 | -25.13% |
| 31 Dec, 22 | 103,749,965 | 21.76% |
| 30 Sep, 22 | 85,208,724 | 33.78% |
| 30 Jun, 22 | 63,691,660 | 6.39% |
| 31 Mar, 22 | 59,863,590 | 1.90% |
| 31 Dec, 21 | 58,745,630 | 7.44% |
| 30 Sep, 21 | 54,679,429 | 3.00% |
| 30 Jun, 21 | 53,088,556 | -2.17% |
| 31 Mar, 21 | 54,263,406 | 2.17% |
| 31 Dec, 20 | 53,109,531 | -4.27% |
| 30 Sep, 20 | 55,480,044 | 5.75% |
| 30 Jun, 20 | 52,465,783 | 34.39% |
| 31 Mar, 20 | 39,039,227 | -3.41% |
| 31 Dec, 19 | 40,415,615 | -2.23% |
| 30 Sep, 19 | 41,336,727 | 12.67% |
| 30 Jun, 19 | 36,689,387 | 2.21% |
| 31 Mar, 19 | 35,897,648 | - |
Gossamer Bio (GOSS) has 182.34M shares outstanding as of 30 Jun 24, down -7.82% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 80.78% | 1.05% |
| 31 Mar, 24 | 87.63% | 1.02% |
| 31 Dec, 23 | 92.80% | 0.82% |
| 30 Sep, 23 | 106.08% | 10.26% |
| 30 Jun, 23 | 32.15% | 1.98% |
| 31 Mar, 23 | 40.27% | 1.39% |
| 31 Dec, 22 | 53.79% | 2.76% |
| 30 Sep, 22 | 44.18% | 4.05% |
| 30 Jun, 22 | 33.02% | 3.43% |
| 31 Mar, 22 | 31.04% | 3.35% |
| 31 Dec, 21 | 30.46% | 3.79% |
| 30 Sep, 21 | 28.35% | 3.74% |
| 30 Jun, 21 | 27.52% | 3.48% |
| 31 Mar, 21 | 28.13% | 3.71% |
| 31 Dec, 20 | 27.53% | 3.33% |
| 30 Sep, 20 | 28.76% | 3.89% |
| 30 Jun, 20 | 27.20% | 6.64% |
| 31 Mar, 20 | 20.24% | 4.61% |
| 31 Dec, 19 | 20.95% | 4.56% |
| 30 Sep, 19 | 21.43% | 5.92% |
| 30 Jun, 19 | 19.02% | 5.49% |
| 31 Mar, 19 | 18.61% | - |
As of 30 Jun 24, Gossamer Bio is held by 80.78% institutional shareholders, representing a 1.05% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 40 | -24.53% |
| 31 Mar, 24 | 53 | -3.64% |
| 31 Dec, 23 | 55 | -11.29% |
| 30 Sep, 23 | 62 | 106.67% |
| 30 Jun, 23 | 30 | -43.40% |
| 31 Mar, 23 | 53 | -26.39% |
| 31 Dec, 22 | 72 | -30.77% |
| 30 Sep, 22 | 104 | 85.71% |
| 30 Jun, 22 | 56 | -22.22% |
| 31 Mar, 22 | 72 | 16.13% |
| 31 Dec, 21 | 62 | 12.73% |
| 30 Sep, 21 | 55 | 14.58% |
| 30 Jun, 21 | 48 | -18.64% |
| 31 Mar, 21 | 59 | -11.94% |
| 31 Dec, 20 | 67 | -4.29% |
| 30 Sep, 20 | 70 | -19.54% |
| 30 Jun, 20 | 87 | 85.11% |
| 31 Mar, 20 | 47 | -18.97% |
| 31 Dec, 19 | 58 | 5.45% |
| 30 Sep, 19 | 55 | 34.15% |
| 30 Jun, 19 | 41 | -42.25% |
| 31 Mar, 19 | 71 | - |
40 institutional shareholders have increased their position in GOSS stock as of 30 Jun 24 compared to 53 in the previous quarter (a -24.53% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 28 | -9.68% |
| 31 Mar, 24 | 31 | 47.62% |
| 31 Dec, 23 | 21 | 16.67% |
| 30 Sep, 23 | 18 | -57.14% |
| 30 Jun, 23 | 42 | 5.00% |
| 31 Mar, 23 | 40 | 14.29% |
| 31 Dec, 22 | 35 | -2.78% |
| 30 Sep, 22 | 36 | -29.41% |
| 30 Jun, 22 | 51 | 24.39% |
| 31 Mar, 22 | 41 | -2.38% |
| 31 Dec, 21 | 42 | 27.27% |
| 30 Sep, 21 | 33 | -8.33% |
| 30 Jun, 21 | 36 | -14.29% |
| 31 Mar, 21 | 42 | 40.00% |
| 31 Dec, 20 | 30 | -3.23% |
| 30 Sep, 20 | 31 | 121.43% |
| 30 Jun, 20 | 14 | -54.84% |
| 31 Mar, 20 | 31 | 40.91% |
| 31 Dec, 19 | 22 | 57.14% |
| 30 Sep, 19 | 14 | -33.33% |
| 30 Jun, 19 | 21 | - |
| 31 Mar, 19 | - | - |
28 institutional shareholders have reduced their position in GOSS stock as of 30 Jun 24 compared to 31 in the previous quarter (a -9.68% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 93 | -17.70% | 182,340,737 | -7.82% | 80.78% | 1.05% | 40 | -24.53% | 28 | -9.68% |
| 31 Mar, 24 | 113 | 11.88% | 197,807,122 | -5.44% | 87.63% | 1.02% | 53 | -3.64% | 31 | 47.62% |
| 31 Dec, 23 | 101 | 4.12% | 209,180,750 | 2.23% | 92.80% | 0.82% | 55 | -11.29% | 21 | 16.67% |
| 30 Sep, 23 | 97 | -4.90% | 204,619,551 | 229.98% | 106.08% | 10.26% | 62 | 106.67% | 18 | -57.14% |
| 30 Jun, 23 | 102 | -8.93% | 62,010,363 | -20.17% | 32.15% | 1.98% | 30 | -43.40% | 42 | 5.00% |
| 31 Mar, 23 | 112 | -10.40% | 77,679,955 | -25.13% | 40.27% | 1.39% | 53 | -26.39% | 40 | 14.29% |
| 31 Dec, 22 | 125 | -29.78% | 103,749,965 | 21.76% | 53.79% | 2.76% | 72 | -30.77% | 35 | -2.78% |
| 30 Sep, 22 | 178 | 26.24% | 85,208,724 | 33.78% | 44.18% | 4.05% | 104 | 85.71% | 36 | -29.41% |
| 30 Jun, 22 | 141 | -4.08% | 63,691,660 | 6.39% | 33.02% | 3.43% | 56 | -22.22% | 51 | 24.39% |
| 31 Mar, 22 | 147 | 6.52% | 59,863,590 | 1.90% | 31.04% | 3.35% | 72 | 16.13% | 41 | -2.38% |
| 31 Dec, 21 | 138 | 6.15% | 58,745,630 | 7.44% | 30.46% | 3.79% | 62 | 12.73% | 42 | 27.27% |
| 30 Sep, 21 | 130 | 10.17% | 54,679,429 | 3.00% | 28.35% | 3.74% | 55 | 14.58% | 33 | -8.33% |
| 30 Jun, 21 | 118 | -7.81% | 53,088,556 | -2.17% | 27.52% | 3.48% | 48 | -18.64% | 36 | -14.29% |
| 31 Mar, 21 | 128 | 0.79% | 54,263,406 | 2.17% | 28.13% | 3.71% | 59 | -11.94% | 42 | 40.00% |
| 31 Dec, 20 | 127 | -1.55% | 53,109,531 | -4.27% | 27.53% | 3.33% | 67 | -4.29% | 30 | -3.23% |
| 30 Sep, 20 | 129 | 13.16% | 55,480,044 | 5.75% | 28.76% | 3.89% | 70 | -19.54% | 31 | 121.43% |
| 30 Jun, 20 | 114 | 6.54% | 52,465,783 | 34.39% | 27.20% | 6.64% | 87 | 85.11% | 14 | -54.84% |
| 31 Mar, 20 | 107 | 10.31% | 39,039,227 | -3.41% | 20.24% | 4.61% | 47 | -18.97% | 31 | 40.91% |
| 31 Dec, 19 | 97 | 10.23% | 40,415,615 | -2.23% | 20.95% | 4.56% | 58 | 5.45% | 22 | 57.14% |
| 30 Sep, 19 | 88 | 18.92% | 41,336,727 | 12.67% | 21.43% | 5.92% | 55 | 34.15% | 14 | -33.33% |
| 30 Jun, 19 | 74 | 4.23% | 36,689,387 | 2.21% | 19.02% | 5.49% | 41 | -42.25% | 21 | - |
| 31 Mar, 19 | 71 | - | 35,897,648 | - | 18.61% | - | 71 | - | - | - |
Gossamer Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Gossamer Bio's stock was made by Aranda Richard on Jun 25 2024, selling 1,908 shares at $0.66 per share (valued at $1.26K). The last insider buy of GOSS was made by Hasnain Faheem on Jun 24 2024, buying 372,000 shares at $0.67 per share (worth $250.28K).
Gossamer Bio Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 7 | 1 | 700.00% |
| Q1 2024 | 7 | 5 | 140.00% |
| Q4 2023 | 9 | - | - |
| Q3 2023 | 6 | - | - |
| Q2 2023 | 28 | 22 | 127.27% |
| Q1 2023 | 4 | 3 | 133.33% |
| Q4 2022 | 6 | 4 | 150.00% |
| Q3 2022 | 4 | 1 | 400.00% |
| Q2 2022 | 10 | 2 | 500.00% |
| Q1 2022 | 6 | 6 | 100.00% |
| Q4 2021 | - | 3 | - |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 13 | 18 | 72.22% |
| Q1 2021 | 8 | 3 | 266.67% |
| Q4 2020 | 3 | - | - |
| Q2 2020 | 7 | - | - |
| Q1 2020 | 10 | - | - |
| Q4 2019 | 2 | 5 | 40.00% |
| Q3 2019 | 4 | 10 | 40.00% |
| Q2 2019 | 7 | - | - |
7 total buy trades, and 1 total sell trades (buy/sell ratio of 7.00%) were made by Gossamer Bio's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 3 | 1 | 300.00% |
| Q1 2024 | - | 5 | - |
| Q4 2023 | 2 | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | 1 | 1 | 100.00% |
| Q1 2023 | 2 | 3 | 66.67% |
| Q4 2022 | - | 4 | - |
| Q3 2022 | 4 | 1 | 400.00% |
| Q2 2022 | - | 2 | - |
| Q1 2022 | - | 6 | - |
| Q4 2021 | - | 3 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 3 | - |
| Q4 2020 | 3 | - | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | 2 | - |
| Q3 2019 | 4 | 10 | 40.00% |
| Q2 2019 | 1 | - | - |
As of Q2 2024, Insider owners conducted 3 open market buy trades and 1 open market sell trades of Gossamer Bio's stocks.
Gossamer Bio Peer Ownership
| Ticker | Company |
|---|---|
| AKRO | Akero Therapeutics, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| FDMT | 4D Molecular Therapeutics, Inc. |
| BMEA | Biomea Fusion, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ALEC | Alector, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| REPL | Replimune Group, Inc. |
| BCEL | Atreca, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| KRON | Kronos Bio, Inc. |
| PASG | Passage Bio, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| FIXX | Q32 Bio Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
GOSS Ownership FAQ
Who Owns Gossamer Bio?
Gossamer Bio is owned by institutional shareholders (80.78%), insiders (2.95%), and public (16.27%). The largest institutional shareholder of Gossamer Bio is NEA MANAGEMENT COMPANY, LLC (8.02% of total shares) and the top mutual fund owner is Clough Global Dividend & Income Fund (10.19% of total shares).
Who are the major institutional shareholders of Gossamer Bio?
Gossamer Bio's major institutional shareholders are NEA MANAGEMENT COMPANY, LLC, ARTAL GROUP S.A., VANGUARD GROUP INC, OCTAGON CAPITAL ADVISORS LP, and ARCH VENTURE MANAGEMENT, LLC. The top five shareholders own together 26.76% of the company's share outstanding.
How many Gossamer Bio shareholders are there?
As of Jun 2024, there are 93 institutional shareholders of Gossamer Bio.
What percentage of Gossamer Bio is owned by NEA MANAGEMENT COMPANY, LLC?
NEA MANAGEMENT COMPANY, LLC owns 18.09M shares of Gossamer Bio, representing 8.02% of the company's total shares outstanding, valued at $16.3M (as of Jun 2024).
What percentage of Gossamer Bio is owned by ARTAL GROUP S.A?
As of Jun 2024, ARTAL GROUP S.A holds 13.31M shares of Gossamer Bio (GOSS), compromising 5.90% of the company, valued at $11.99M.
What percentage of Gossamer Bio is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Gossamer Bio. The company owns 11.76M of the company's shares outstanding (worth $10.59M).